Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | hydroxyprostaglandin dehydrogenase 15-(NAD) | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Plasmodium falciparum | steroid dehydrogenase, putative | hydroxyprostaglandin dehydrogenase 15-(NAD) | 266 aa | 216 aa | 22.2 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0083 | 0.2817 | 0.5 |
Mycobacterium tuberculosis | Possible lysophospholipase | 0.0083 | 0.2817 | 1 |
Chlamydia trachomatis | glutamyl-tRNA(Gln) amidotransferase subunit A | 0.0027 | 0 | 0.5 |
Plasmodium falciparum | lysophospholipase, putative | 0.0083 | 0.2817 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0083 | 0.2817 | 0.5 |
Plasmodium vivax | PST-A protein | 0.0083 | 0.2817 | 1 |
Trypanosoma cruzi | monoglyceride lipase, putative | 0.0083 | 0.2817 | 1 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0083 | 0.2817 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0226 | 1 | 1 |
Wolbachia endosymbiont of Brugia malayi | aspartyl/glutamyl-tRNA amidotransferase subunit A | 0.0027 | 0 | 0.5 |
Mycobacterium ulcerans | lysophospholipase | 0.0083 | 0.2817 | 1 |
Echinococcus granulosus | fatty acid amide hydrolase 1 | 0.0226 | 1 | 1 |
Plasmodium falciparum | esterase, putative | 0.0083 | 0.2817 | 1 |
Mycobacterium ulcerans | hypothetical protein | 0.0083 | 0.2817 | 1 |
Echinococcus multilocularis | fatty acid amide hydrolase 1 | 0.0226 | 1 | 1 |
Entamoeba histolytica | hydrolase, alpha/beta fold family domain containing protein | 0.0083 | 0.2817 | 0.5 |
Echinococcus multilocularis | fatty acid amide hydrolase 1 | 0.0226 | 1 | 1 |
Plasmodium falciparum | lysophospholipase, putative | 0.0083 | 0.2817 | 1 |
Trypanosoma brucei | monoglyceride lipase, putative | 0.0083 | 0.2817 | 1 |
Schistosoma mansoni | amidase | 0.0226 | 1 | 1 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0083 | 0.2817 | 0.5 |
Treponema pallidum | aspartyl/glutamyl-tRNA amidotransferase subunit A | 0.0027 | 0 | 0.5 |
Plasmodium falciparum | lysophospholipase, putative | 0.0083 | 0.2817 | 1 |
Echinococcus granulosus | fatty acid amide hydrolase 1 | 0.0226 | 1 | 1 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0083 | 0.2817 | 0.5 |
Mycobacterium leprae | POSSIBLE LYSOPHOSPHOLIPASE | 0.0083 | 0.2817 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0083 | 0.2817 | 0.5 |
Trypanosoma brucei | monoglyceride lipase, putative | 0.0083 | 0.2817 | 1 |
Entamoeba histolytica | hydrolase, alpha/beta fold family domain containing protein | 0.0083 | 0.2817 | 0.5 |
Leishmania major | monoglyceride lipase, putative | 0.0083 | 0.2817 | 1 |
Trichomonas vaginalis | valacyclovir hydrolase, putative | 0.0083 | 0.2817 | 0.5 |
Schistosoma mansoni | fatty-acid amide hydrolase | 0.0226 | 1 | 1 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0083 | 0.2817 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 2.2387 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase). (Class of assay: confirmatory) [Related pubchem assays: 2429 (Confirmation qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2407 (Probe Development Summary for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2427 (Thermal Shift Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase))] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.